Telesis Bio (TBIO) Competitors

Talis Biomedical (NASDAQ:TLIS) and Telesis Bio (NASDAQ:TBIO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Which has stronger earnings & valuation, TLIS or TBIO?

Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talis Biomedical	$2.13M	1.46	-$62.01M	-$28.02	-0.06
Telesis Bio	$27.51M	0.06	-$47.72M	-$28.20	-0.03

Does the media refer more to TLIS or TBIO?

In the previous week, Talis Biomedical's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
Talis Biomedical	Neutral
Telesis Bio	Neutral

Which has more volatility and risk, TLIS or TBIO?

Talis Biomedical has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500.

Is TLIS or TBIO more profitable?

Telesis Bio has a net margin of -336.59% compared to Talis Biomedical's net margin of -5,784.73%. Talis Biomedical's return on equity of -79.74% beat Telesis Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talis Biomedical	-5,784.73%	-79.74%	-57.16%
Telesis Bio	-336.59%	-359.32%	-61.89%

Do insiders and institutionals believe in TLIS or TBIO?

43.8% of Talis Biomedical shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 46.0% of Talis Biomedical shares are owned by company insiders. Comparatively, 24.5% of Telesis Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer TLIS or TBIO?

Talis Biomedical and Telesis Bio both received 9 outperform votes by MarketBeat users. However, 52.94% of users gave Telesis Bio an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote.

Company	Underperform	Outperform
Talis Biomedical	Outperform Votes 9 37.50%	Underperform Votes 15 62.50%
Telesis Bio	Outperform Votes 9 52.94%	Underperform Votes 8 47.06%

Summary

Talis Biomedical and Telesis Bio tied by winning 6 of the 12 factors compared between the two stocks.